Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
100 participants
OBSERVATIONAL
2024-05-31
2027-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Muscle Trajectories in Acute Stroke Patients
NCT04337411
Visual Observation Scale for the Upper Limb During Walking in Patients After Stroke.
NCT05128370
Use of Surface Electromyography as a Tools to Predict Upper Extremity Recovery Function After Stroke
NCT06574737
Impact of Muscular Fatigability on Spastic Co-contractions After Stroke Patients
NCT03342820
Muscle Synergies After Stroke
NCT03731299
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
On each of the four time-points, the investigators will assess muscle specific parameters of the affected m. rectus femoris (RF) and m. gastrocnemius medialis (GM), together with clinical tests to assess lower limb impairment (Fugl-Meyer Assessment for the lower limb and the Tardieu scale) and gait parameters (10-meter walk test). Specifically, muscle specific parameters will be investigated using 3D freehand ultrasound (3DfUS) and combined dynamic 2D US and surface electromyography (sEMG). Such assessments will help us characterize the electromechanical properties of these muscles, their time-related trajectories and the relationship with the recovery of gait and lower limb function after stroke. At the end of the investigation period, after 3 months, patients who can walk independently will perform a 3D gait analysis. As such, the relationship between changes in muscle specific parameters and the eventual gait quality at the end of the investigation period will be investigated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients in the first 3 months after stroke
Inclusion criteria:
Adults (≥ 18 years old) Diagnosed with a first-ever stroke (as defined by WHO) Stroke onset ≤ 1 week (± 3 days) Able to provide written or verbal informed consent at admission Presence of gait problems as a consequence of the stroke (FAC≤4)
Exclusion criteria:
Presence of other neurological or orthopedic problems present prior to, or not caused as a direct consequence of, the stroke leading to impaired gait.
Modified Ranking scale pre-stroke \> 1/6, meaning presence of slight disability before the stroke.
Presence of severe comorbidities (e.g. osteoporosis, cardiovascular instability or chronic obstructive pulmonary disease).
Cerebellar or bilateral stroke. Presence of severe deficits in communication, memory or understanding precluding informed consent.
Longitudinal prospective cohort study
Patients after stroke who meet the in- and exclusion criteria will be examined 4 times during the first 3 months after their stroke.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Longitudinal prospective cohort study
Patients after stroke who meet the in- and exclusion criteria will be examined 4 times during the first 3 months after their stroke.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with a first-ever stroke (as defined by WHO)
* Stroke onset ≤ 1 week (± 3 days)
* Able to provide written or verbal informed consent at admission
* Presence of gait problems as a consequence of the stroke (FAC≤4)
Exclusion Criteria
* Modified Ranking scale pre-stroke \> 1/6, meaning presence of slight disability before the stroke.
* Presence of severe comorbidities (e.g. osteoporosis, cardiovascular instability or chronic obstructive pulmonary disease).
* Cerebellar or bilateral stroke.
* Presence of severe deficits in communication, memory or understanding precluding informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Ghent
OTHER
Research Foundation Flanders
OTHER
Vrije Universiteit Brussel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eva Swinnen
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eva Swinnen, Professor
Role: PRINCIPAL_INVESTIGATOR
Vrije Universiteit Brussel
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Smith MC, Barber AP, Scrivener BJ, Stinear CM. The TWIST Tool Predicts When Patients Will Recover Independent Walking After Stroke: An Observational Study. Neurorehabil Neural Repair. 2022 Jul;36(7):461-471. doi: 10.1177/15459683221085287. Epub 2022 May 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23485_StrIMuC12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.